NEW YORK (GenomeWeb News) - The US Department of Defense has awarded CombiMatrix a one-year, $2.2 million contract to continue developing its microarrays to detect pathogens and toxins for use in bio-terror defense, CombiMatrix said today.
 
The company said under earlier DoD-funded programs it “demonstrated that its products can “simultaneously detect toxins, viruses, and bacteria using its semiconductor-based microarrays.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.